RecruitingNCT06707012
Metformin added to antidepressants for adults with obesity and depression
About this title
Read the official source — NCT06707012Medication studyAges 18–45Pakistan
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.
- Listed locations
- Karachi and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: October 1, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 140
- Sponsor
- Fazaia Ruth Pfau Medical College
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Pakistan
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT06707012
- Official title
Show the full official title
Efficacy of Metformin as an Adjunct to Standard Antidepressant Therapy in Treating Depression Among Obese Patients
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Karachi
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Fazaia Ruth Pfau Medical College, a university.
Does this study involve medication?
Yes. The study involves medication, including Metformin Hydrochloride.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
